Economic evaluation of a combined DTPa, hepatitis B, polio, Hib vaccine. Potential impact of the introduction of Infanrix-Hexa in the French childhood immunisation schedule.
Fagnani
Francis
F
CEMKA, 43 Boulevard Maréchal Joffre, 92340 Bourg-la-Reine, France. francis.fagnani@cemka.fr
Le Fur
Camille
C
Durand
Isabelle
I
Gibergy
Michel
M
D016667:Bacterial Capsules; D002648:Child; D003365:Costs and Cost Analysis; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000008:administration & dosage / Q000191:economics; D005602:France; D018073:Haemophilus Vaccines / Q000008:administration & dosage / Q000191:economics; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000191:economics; D006801:Humans; D007115:Immunization Schedule; D023321:Poliovirus Vaccines / Q000008:administration & dosage / Q000191:economics; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000191:economics; D017778:Vaccines, Combined / Q000008:administration & dosage / Q000191:economics
D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D017325:Hepatitis B Vaccines; D023321:Poliovirus Vaccines; D011135:Polysaccharides, Bacterial; D017778:Vaccines, Combined